Ken Solovay, former Chief Operating Officer. Ken had 30 years of experience in the healthcare industry, including positions in product development and program management at Johnson & Johnson and C.R. Bard, as well as executive management roles at the start-up ventures Aspiration Medical Technology (AMT), GMP Companies, and Seedlings Life Science Ventures. As President of AMT, Ken was responsible for bringing an obesity treatment from concept through development and validation in clinical trials, and he was instrumental in the company completing a $16 million Series D capital fundraise that ultimately led to FDA PMA approval. Ken had extensive experience developing implantable devices with minimally invasive delivery systems and held 40 US patents. He earned an M.S. in Biomedical Engineering from the University of Alabama at Birmingham with an expertise in Biomaterials, and a B.S. in Materials Science & Engineering from the University of Florida.
ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay